HUP0300828A2 - Eljárás N-aril-antranilsavak és e vegyületek származékainak elżállítására - Google Patents

Eljárás N-aril-antranilsavak és e vegyületek származékainak elżállítására Download PDF

Info

Publication number
HUP0300828A2
HUP0300828A2 HU0300828A HUP0300828A HUP0300828A2 HU P0300828 A2 HUP0300828 A2 HU P0300828A2 HU 0300828 A HU0300828 A HU 0300828A HU P0300828 A HUP0300828 A HU P0300828A HU P0300828 A2 HUP0300828 A2 HU P0300828A2
Authority
HU
Hungary
Prior art keywords
formula
group
alkyl
hydrogen
atom
Prior art date
Application number
HU0300828A
Other languages
English (en)
Hungarian (hu)
Inventor
Michael Huai Gu Chen
Edward Mark Davis
Javier Magano
Thomas Norman Nanninga
Derick Dale Winkle
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of HUP0300828A2 publication Critical patent/HUP0300828A2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
HU0300828A 2000-08-25 2001-07-20 Eljárás N-aril-antranilsavak és e vegyületek származékainak elżállítására HUP0300828A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22820600P 2000-08-25 2000-08-25
PCT/US2001/022948 WO2002018319A1 (fr) 2000-08-25 2001-07-20 Procede de fabrication d'acides n-aryle-anthraniliques et de leurs derives

Publications (1)

Publication Number Publication Date
HUP0300828A2 true HUP0300828A2 (hu) 2003-09-29

Family

ID=22856235

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300828A HUP0300828A2 (hu) 2000-08-25 2001-07-20 Eljárás N-aril-antranilsavak és e vegyületek származékainak elżállítására

Country Status (32)

Country Link
EP (1) EP1313694A1 (fr)
JP (1) JP2004507518A (fr)
KR (1) KR20030059115A (fr)
CN (1) CN1458921A (fr)
AP (1) AP2001002249A0 (fr)
AR (1) AR032175A1 (fr)
AU (1) AU2001277044A1 (fr)
BG (1) BG107635A (fr)
BR (1) BR0113520A (fr)
CA (1) CA2420003A1 (fr)
CZ (1) CZ2003477A3 (fr)
DO (1) DOP2001000238A (fr)
EA (1) EA200300187A1 (fr)
GT (1) GT200100174A (fr)
HN (1) HN2001000216A (fr)
HU (1) HUP0300828A2 (fr)
IL (1) IL154507A0 (fr)
IS (1) IS6724A (fr)
MA (1) MA26949A1 (fr)
MX (1) MXPA03001654A (fr)
NO (1) NO20030844L (fr)
PA (1) PA8526501A1 (fr)
PE (1) PE20020393A1 (fr)
PL (1) PL360699A1 (fr)
PY (1) PY0120841A (fr)
SK (1) SK2072003A3 (fr)
SV (1) SV2002000601A (fr)
TN (1) TNSN01127A1 (fr)
UY (1) UY26908A1 (fr)
WO (1) WO2002018319A1 (fr)
YU (1) YU14303A (fr)
ZA (1) ZA200301182B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100984595B1 (ko) 2002-03-13 2010-09-30 어레이 바이오파마 인크. Mek 억제제로서의 n3 알킬화 벤즈이미다졸 유도체
US7235537B2 (en) 2002-03-13 2007-06-26 Array Biopharma, Inc. N3 alkylated benzimidazole derivatives as MEK inhibitors
US7144907B2 (en) 2003-09-03 2006-12-05 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7538120B2 (en) 2003-09-03 2009-05-26 Array Biopharma Inc. Method of treating inflammatory diseases
NZ546011A (en) 2003-10-21 2009-09-25 Warner Lambert Co Polymorphic form of N-[(R)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
CN1905873A (zh) 2003-11-19 2007-01-31 阵列生物制药公司 Mek的杂环抑制剂及其使用方法
US7517994B2 (en) 2003-11-19 2009-04-14 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7732616B2 (en) 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
NZ590160A (en) 2003-11-21 2012-07-27 Array Biopharma Inc AKT protein kinase inhibitors
UA89035C2 (ru) * 2003-12-03 2009-12-25 Лео Фарма А/С Эфиры гидроксамовых кислот и их фармацевтическое применение
JP5154406B2 (ja) 2005-04-13 2013-02-27 アステックス、セラピューティックス、リミテッド 医薬化合物
ES2405785T3 (es) 2005-05-18 2013-06-03 Array Biopharma Inc. Inhibidores heterocíclicos de MEK y métodos de uso de los mismos
US7754725B2 (en) 2006-03-01 2010-07-13 Astex Therapeutics Ltd. Dihydroxyphenyl isoindolymethanones
ATE523499T1 (de) 2006-07-06 2011-09-15 Array Biopharma Inc Cyclopenta [d]-pyrimidine als akt-proteinkinasehemmer
ATE532789T1 (de) 2006-07-06 2011-11-15 Array Biopharma Inc Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren
CA2656566C (fr) 2006-07-06 2014-06-17 Array Biopharma Inc. Dihydrofuro pyrimidines comme inhibiteurs de la proteine kinase akt
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
EP2073802A1 (fr) 2006-10-12 2009-07-01 Astex Therapeutics Limited Combinaisons pharmaceutiques
JP5410285B2 (ja) 2006-10-12 2014-02-05 アステックス、セラピューティックス、リミテッド 医薬化合物
JP5518478B2 (ja) 2006-10-12 2014-06-11 アステックス、セラピューティックス、リミテッド 医薬化合物
WO2008044041A1 (fr) 2006-10-12 2008-04-17 Astex Therapeutics Limited Combinaisons pharmaceutiques
GB0620259D0 (en) 2006-10-12 2006-11-22 Astex Therapeutics Ltd Pharmaceutical compounds
EP2073807A1 (fr) 2006-10-12 2009-07-01 Astex Therapeutics Limited Combinaisons pharmaceutiques
US8846683B2 (en) 2007-07-05 2014-09-30 Array Biopharma, Inc. Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
WO2009006567A2 (fr) 2007-07-05 2009-01-08 Array Biopharma Inc. Cyclopentanes de pyrimidyle comme inhibiteurs de protéines kinases akt
US9409886B2 (en) 2007-07-05 2016-08-09 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
CN101918373B (zh) 2007-07-05 2013-06-05 阵列生物制药公司 作为akt蛋白激酶抑制剂的嘧啶基环戊烷
ES2422733T3 (es) 2008-01-09 2013-09-13 Array Biopharma Inc Pirimidilciclopentanos hidroxilados como inhibidores de proteínas cinasas AKT
EP2240455B1 (fr) 2008-01-09 2012-12-26 Array Biopharma, Inc. Pyrimidyl cyclopentane hydroxylé en tant qu'inhibiteur de protéine kinase akt
GB0806527D0 (en) 2008-04-11 2008-05-14 Astex Therapeutics Ltd Pharmaceutical compounds
CN101985428B (zh) * 2009-07-29 2014-02-12 杭州民生药业有限公司 邻苯胺基苯甲酸衍生物或其药学上可接受的盐、其制备方法及其用途
JP2013519714A (ja) * 2010-02-19 2013-05-30 センター ナショナル デ ラ リシェルシェ サイエンティフィック 芳香族求核置換によって目的の化学化合物を調製するための方法
CN102985399A (zh) * 2010-02-19 2013-03-20 国家科学研究中心 通过对携带至少一个吸电子基团的芳香族羧酸衍生物进行亲核芳香族取代来制备目的化合物的方法
WO2012135781A1 (fr) 2011-04-01 2012-10-04 Genentech, Inc. Combinaisons de composés inhibiteurs d'akt et d'agents chimiothérapeutiques, et procédés d'utilisation
RU2013148817A (ru) 2011-04-01 2015-05-10 Дженентек, Инк. Комбинации соединений-ингибиторов акт и мек и способы их применения
KR102204520B1 (ko) * 2012-10-12 2021-01-20 엑셀리시스, 인코포레이티드 암의 치료에 사용하기 위한 화합물의 신규 제조 방법
CN112745237B (zh) * 2019-10-29 2023-06-20 中国科学院上海药物研究所 2-芳基胺类化合物及其制备方法和应用
CN119948008B (zh) * 2022-07-15 2026-04-28 南方科技大学 一种以异腈和环丙烯为原料制备稠环芳胺的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138636A (en) * 1960-06-23 1964-06-23 Parke Davis & Co Anthranilic acid derivatives
AU5610398A (en) * 1997-02-28 1998-09-18 Warner-Lambert Company Method of treating or preventing septic shock by administering a mek inhibitor
NZ501276A (en) * 1997-07-01 2000-10-27 Warner Lambert Co 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors in treating proliferative disorders
BR9810385A (pt) * 1997-07-01 2000-09-05 Warner Lambert Co Derivados de ácido benzóico 2-(4-bromo ou 4-iodo fenilamino) e sua utilização como inibidores de mek
CA2348236A1 (fr) * 1999-01-13 2000-07-20 Stephen Douglas Barrett 4-arylamino, 4-aryloxy, et 4-arylthio diarylamines et leurs derives comme inhibiteurs selectifs de mek
PT1171418E (pt) * 1999-04-21 2005-02-28 Warner Lambert Co Metodo de preparacao de acidos 2-(n-fenilamino)benzoicos

Also Published As

Publication number Publication date
JP2004507518A (ja) 2004-03-11
YU14303A (sh) 2006-08-17
BG107635A (bg) 2004-09-30
NO20030844D0 (no) 2003-02-24
PA8526501A1 (es) 2002-07-30
BR0113520A (pt) 2003-06-24
TNSN01127A1 (en) 2005-11-10
WO2002018319A1 (fr) 2002-03-07
HN2001000216A (es) 2002-05-22
PL360699A1 (en) 2004-09-20
PY0120841A (es) 2004-06-01
CN1458921A (zh) 2003-11-26
KR20030059115A (ko) 2003-07-07
ZA200301182B (en) 2004-05-12
AU2001277044A1 (en) 2002-03-13
CZ2003477A3 (cs) 2003-10-15
SK2072003A3 (en) 2004-01-08
EP1313694A1 (fr) 2003-05-28
GT200100174A (es) 2002-07-18
DOP2001000238A (es) 2003-01-31
PE20020393A1 (es) 2002-05-09
SV2002000601A (es) 2002-04-03
MXPA03001654A (es) 2004-09-10
MA26949A1 (fr) 2004-12-20
AP2001002249A0 (en) 2001-09-30
AR032175A1 (es) 2003-10-29
IS6724A (is) 2003-02-20
NO20030844L (no) 2003-02-25
CA2420003A1 (fr) 2002-03-07
EA200300187A1 (ru) 2003-08-28
IL154507A0 (en) 2003-09-17
UY26908A1 (es) 2001-11-30

Similar Documents

Publication Publication Date Title
HUP0300828A2 (hu) Eljárás N-aril-antranilsavak és e vegyületek származékainak elżállítására
CN104892490B (zh) 用于制备光学活性二氮杂环辛烷衍生物的中间体化合物的化合物
TWI481606B (zh) 二苯基吡唑并吡啶衍生物、其製備及其治療用途
NZ333696A (en) Amidinoindoles, amidinoazoles, and analogs thereof as inhibitors of trypsin like protease enzymes like thrombin and Xa factor
IT8149086A1 (it) Composti eterociclici indolici, procedimento per produrli e composizioni farmaceutiche che li contengono
EP2409967A1 (fr) Polymorphes de n-hydroxy-3-[4-[[[2-(2-méthyl-1h-indol-3-yl)éthyl]amino]méthyl]phényl]-2e-2-propénamide
JP2016540024A (ja) 新規な選択的ヒストン脱アセチル化酵素阻害剤としてのアザインドール誘導体およびこれを含む薬剤学的組成物
KR102791742B1 (ko) (s)-3-아미노-4-(디플루오로메틸레닐)사이클로펜트-1-엔-1-카르복실산의 합성을 위한 공정
CN115427419A (zh) P2x3拮抗剂的制备
HUP0300701A2 (hu) Zolpidem hemitartarát, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények
CN106536479B (zh) 用于制备β-氨基砜化合物的方法
JPH06293742A (ja) イミダゾール化合物とその製造及び使用方法
US20040039208A1 (en) Process for making n-aryl-anthranilic acids and their derivatives
JP4656696B2 (ja) ノイラミニダーゼ阻害剤の調製方法
US20020002170A1 (en) Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation
AU2004287810A1 (en) Process for the preparation of CCR-2 antagonist
JP4208464B2 (ja) ナフチリジン−3−カルボン酸誘導体の製造法
JP3748821B2 (ja) α−(2−4−ジスルホフェニル)−N−tert−ブチルニトロン及びその医薬上許容しうる塩の新規な製造方法
US20170174633A1 (en) Pyrazole compounds selective for neurotensin 2 receptor
CN103328471A (zh) 制备氮杂吲唑衍生物的方法
CN1351600A (zh) 制备[S-(R*,S*)]-β-[[[1-[1-氧代-3-(4-(哌啶基)丙基]-3-哌啶基]羰基]氨基]-3-吡啶丙酸及其衍生物的方法
CN103958466B (zh) 作为crth2拮抗剂的含氮并环化合物
CN105934431B (zh) 取代脲类化合物的制备方法
RU2195450C2 (ru) Новые способы и промежуточные соединения
JP4898287B2 (ja) [1−[2−[4−[n−(5−メチルピリジン−2−イル)−2−フランカルボキサミド]ピペリジン−1−イル]エチル]シクロヘキシル]アセトヒドロキサム酸の製造方法